The PRO-ACT database is an open-access repository of anonymized clinical trial data focused on amyotrophic lateral sclerosis (ALS). It compiles patient-level information from multiple Phase II and Pha
DNA methylation signatures are highly cell type-specific, yet most epigenome-wide association studies (EWAS) are performed on bulk tissue, potentially obscuring critical cell type-specific patterns. E
Carbon-centered radicals offer unmatched nanometer-scale precision for proximity labeling, yet existing light-driven platforms such as μMap are limited by shallow tissue penetration and phototoxicity.
